Medicines management in the elderly Trudi McIntosh and Kim Munro School of Pharmacy and Life Sciences RGU.

Slides:



Advertisements
Similar presentations
UGA Doctor of Pharmacy Candidate
Advertisements

Medication review at the End of Life
“ Handle with Care” A GP guide to cancer care for elderly patients.
Table 1: Top five examples of PIP according to the STOPP criteria
Prescription Drug Misuse & Abuse in Older Adults INSERT YOUR NAME HERE.
Polypharmacy of Older Adults
Improving Medication Management Support for Older Adults: A Pilot Study Susan L. Lakey, PharmD Acting Assistant Professor University of Washington Department.
E-ARMOR: An Online Tool to Evaluate Polypharmacy in Elderly Persons
Optimising Safe and Appropriate Medicines Use Katie Smith, Director, East Anglia Medicines Information Service October 2013.
Polypharmacy Jillian Hernan Fee, PharmD, BCPS Clinical Pharmacist
Meredith Cook Mercer COPHS August, Beers Criteria AGS and interdisciplinary panel of 11 experts in geriatrics and pharmacotherapy 53 medications.
Division of Population Health Sciences Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn Potentially inappropriate prescribing and.
Disability, Frailty and Co-morbidity Gero 302 Jan 2012.
UMMS CRIT Module II: Drug Therapy in the Elderly Jerry H. Gurwitz, MD Chief, Division of Geriatric Medicine University of Massachusetts Medical School.
Prescription Drug Abuse and Misuse in the Elderly Thomas L. Patterson, Ph.D. Support for this work: NIMH Center Grants P30 MH49693 and MH45131, and by.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
Best Practices for Safe Prescribing in Older ED Patients S. Nicole Hastings, M.D., M.H.S. 1.
Pharmacology in the Elderly. Pharmacological Challenges in the Elderly  Pharmacokinetic changes  Pharmacodynamic changes  Multiple co-morbidities 
Safer Medication & Medical Devices Medication Safety & Hospital Admissions Avoidance 30 th June 2015 Dr Ahmed Ameer Medication Safety.
Clinical Training: Medication Reconciliation
The Prevalence of and Factors Associated with Potentially Inappropriate Medications Use in The Elderly Population in Thailand Rosarin Sruamsiri1, Nathorn.
Substance Abuse in the Elderly: What Every Clinician Should Know Courtney Ghormley, PhD Geriatric Neuropsychology Central Arkansas Veterans Healthcare.
1 Prescribing Omissions according to START and related hospital admission in geriatric patients O. Dalleur 1, A. Spinewine 2, S. Henrard 3, C. Losseau.
Chapter 11: Polypharmacy
Education & Training Curriculum on Multiple Chronic Conditions (MCC) Strategies & tools to support health professionals caring for people living with MCC.
Patricia A. Keys, Pharm.D., C.G.P. Clinical Associate Professor Mylan School of Pharmacy Duquesne University.
Polypharmacy and preventing hospital admissions
APPLICATION OF THE START-STOPP CRITERIA ON AN ELDERLY POPULATION IN BELGIAN GENERAL PRACTICE: an explorative study J. Landa 1, A. Torsin 1, T. Cornelissen.
FHHS ACAT 2012/2013 Audit. A survey of prescribing in the frail elderly with reference to the STOPP criteria.
Use of Implicit Criteria to Determine Appropriateness of Medication in Geriatric Populations Brittany Barnes Pharm.D Candidate 2013, Marilyn N. Bulloch,
Measuring and Evaluating Indicators of Appropriate Prescribing in Older Populations Cahir C., Teeling M., Teljeur C., Bennett K., Fahey T. HRB PhD Scholar.
17 tools identified composed mostly of (>95%) explicit criteria 4 versions of the Beers Criteria were found The original Beers Criteria (1991) or subsequent.
Medication Safety and admissions avoidance: A perspective Steve Williams Consultant Pharmacist in Medicine & Medication Safety Honorary Clinical Lecturer,
Medicines optimisation – a research pharmacist’s perspective Dr David Alldred Senior Lecturer in Pharmacy Practice 23 January 2015Bradford School of Pharmacy1.
Flu Epidemiological Clinical Ethical Philosophical …and older people.
Polypharmacy May 2008 CRIT Heidi Auerbach, MD Copyright Boston University Medical Center.
How to use Comprehensive Geriatric Evaluation to Assess Older People with Diabetes Dr. Leocadio Rodríguez Mañas Dr. Marta Castro Rodríguez.
Comprehensive Geriatric Assessment and the Patient- Centered Clinical Method.
Controlling “Polypharmacy” in the elderly The “Medication Appropriateness Index” G. Vital-Durand 1, F. Herrmann 2, J-P. Michel 2, V. Rollason 3, N. Vogt.
Measuring and Evaluating Indicators of Appropriate Prescribing in Older Populations Cahir C., Teeling M., Feely J, Byrne S., Fahey T., Bennett K. Caitriona.
Care Experience Breakout Sessions Trudi Marshall
Can the evidence base shape our solutions to polypharmacy?
Pharmacotherapy in older age. Changes in pharmacokinetics and pharmacodynamics Polymorbidity, risk of DRUG-DISEASE interactions Polypharmacy, risk of.
Virtual ACE Update.
POLYPHARMACY AND MEDICINES OPTIMISATION Professor Tony Avery, University of Nottingham, in collaboration with Dr Martin Duerden Dr Rupert Payne 1.
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
Consultant Pharmacist, Care of Older People
Amina Mahdy BPharm, MSc, PhD, Dip.ClinPharm Associate Professor, Pharmacology & Therapeutics Dubai Pharmacy College, UAE DPC.
Older people and harms from medicines: A pharmacy perspective Debra Rowett Director Drug and Therapeutics Information Service Repatriation General Hospital,
Medication Non-Adherence: The Hidden Epidemic
Geriatric Medicine Sensible Practice in Modern Societies Liang-Kung Chen, MD PhD FRCP Aging and Health Research Center, National Yang Ming University,
Polypharmacy in a Patient Centered Medical Home Carilion Clinic – VTC Family Medicine Roanoke, Virginia.
Medication Management in the Older Patient. Older adults are more likely to have an Adverse Drug Reaction More likely to be on 5 or more medications Hazzard,
Polypharmacy Review T. Lewis GP. Six principles of medication review Patients should have a chance to raise questions and highlight problems about their.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
Chapter 8: Identifying and Preventing Common Risk Factors in the Elderly.
EVALUATING THE EFFECTIVENESS OF THE AGS UPDATED 2012 BEERS CRITERIA AS AN EDUCATIONAL TOOL IN A FAMILY MEDICINE RESIDENCY TRAINING PROGRAM Eseoghene Abokede.
Priscilla Kim, PharmD PGY-1 Pharmacy Practice Resident St. Joseph’s Regional Medical Center.
Using an EHR Template and the Beer’s List to Address Geriatric Polypharmacy Rose Family Medicine Residency Emily Gutgsell, MD Emma Bjore, MD Anna Plunkett,
Grant Macdonald.  Appropriate polypharmacy describes treatment where a patient has multiple morbidities, and/or a complex condition, that is being managed.
Comorbidity and Multimorbidity: Measurement and Interventions Holly M. Holmes, MD, MS Dept of General Internal Medicine.
The Pharmacists’ role leading medicines optimisation in older people
Problematic Polypharmacy
@Improve_Academy #WeStopMeds.
Polypharmacy In Adults: Small Test of Change
Medicines Optimisation
Does the Beer’s Criteria Influence Prescribing for Geriatric Patients?
What’s New in Medication Management: Focus on Older Adults and Caregivers Tuesday, April 30, :00 Noon CDT Mike Varnell, RPh, CSA (214)
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Presentation transcript:

Medicines management in the elderly Trudi McIntosh and Kim Munro School of Pharmacy and Life Sciences RGU

Objectives To use patient profiles, patient ‘voices’ and validated assessment tools to identify and prioritise elderly patients at risk of medication misadventure To consider options to rationalise these patients’ medication regimens to reduce this risk To consider own prescribing practice in relation to risks of medication misadventure

Medication misadventure? Aging population: co-morbidities polypharmacy + complex medication regimens increased risk of interactions effect of aging on metabolism of drugs reduced dexterity possible cognitive decline social circumstances etc

Guidance: national and local Polypharmacy Guidance 2012 Scottish Government guidance%20v2.pdf guidance%20v2.pdf NHS Grampian guidance on reducing polypharmacy in frail older people

Tools to assess ‘risk’ Beers criteria: potentially inappropriate medication use in older adults STOPP-START: screening tools for potentially inappropriate meds/ right meds Morisky medication adherence scale Medication regimen complexity index Anticholinergic risk scale plus others

Initial thoughts Miss Agnes Smith and Mrs Susan Green Patient profile + Polypharmacy Guidance, Scottish Government. Initial thoughts? Complexity? Medication Regimen Complexity Index

Adherence Miss Agnes Smith and Mrs Susan Green Patient interviews Video clip: ‘Morisky questions’ to assess adherence

Anticholinergic risk scale Anticholinergic burden may contribute to falls, delirium, cognitive impairment, dry mouth, constipation etc Assess patients’ risk of medicine misadventure due to anticholinergic risk

Prioritisation and rationalisation How will you prioritise the patients? How might you start to rationalise their medications? Impact on your own prescribing practice?

References Fick, D.M. et al Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts Archives of Internal Medicine, 163(22), pp. 2716–2724. Gallagher P, et al STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment): Consensus Validation. Int J Clin Pharmacol Therapy, 46(2), pp.72 – 83. George, J. et al., Development and validation of the medication regimen complexity index. The Annals of Pharmacotherapy, 38(9), pp Morisky, D.E., Green, L.W. and Levine, D.M., Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care,;24, pp Rudolph, J.L. et al.,2008. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Archives of Internal Medicine, 168(5), pp